OKYO Pharma Limited Cash And Cash Equivalents
OKYO Pharma Limited (OKYO) had Cash And Cash Equivalents of $4.60 million as of 2025-07-31, per its 20-F filed 2025-07-18.
Financial Statements › Notes
ifrs-full:CashAndCashEquivalents · last filed 2025-07-18
- 2025-07-31: Cash And Cash Equivalents $4.60M.
- 2025-03-31: Cash And Cash Equivalents $1.56M.
- 2024-03-31: Cash And Cash Equivalents $826.85K.
- 2023-03-31: Cash And Cash Equivalents $4.05M.
| Period end | Cash And Cash Equivalents |
|---|---|
| 2025-07-31 | $4.60M 20-F · filed 2025-07-18 |
| 2025-03-31 | $1.56M 20-F · filed 2025-07-18 |
| 2024-03-31 | $826.85K 20-F · filed 2025-07-18 |
| 2023-03-31 | $4.05M 20-F · filed 2025-07-18 |
| 2022-03-31 | $2.70M 20-F · filed 2025-07-18 |
| 2021-03-31 | $6.89M 20-F · filed 2024-08-13 |
| 2020-03-31 | $235.49K 20-F · filed 2023-08-15 |
| 2019-03-31 | $627.62K 20-F · filed 2022-08-15 |